Viatris Inc. (VTRS)
Health Care ยท Pharmaceutical Preparations
Viatris Inc. (VTRS) is listed on Nasdaq, where its shares have traded since February 23, 1973. SentiSense covers Viatris Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Scott A. Smith is its chief executive officer. The company reports 30,000 employees, and its corporate website is www.viatris.com.
About Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
Latest reported results
Viatris Inc. reported revenue of $3.76 billion for Q2 FY2026, up 4.9% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1,007 institutions reported holding VTRS, with 1.0 billion shares worth $16.5 billion in aggregate. The largest reported holders were Vanguard, FMR and BlackRock. Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter.
More on VTRS
- VTRS sentiment: whether news and social coverage of Viatris Inc. leans bullish or bearish, and the stories driving it.
- VTRS ownership: all 1,007 reporting institutions, plus insider and congressional trades.
- VTRS financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for Viatris Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Viatris Inc. do?
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs.
What sector is VTRS in?
SentiSense classifies Viatris Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does VTRS stock trade?
Viatris Inc. (VTRS) is listed on Nasdaq, where its shares have traded since February 23, 1973.
Who is the CEO of Viatris Inc.?
Scott A. Smith is the chief executive officer of Viatris Inc..